Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Revenue | 1.35bn | 808m |
| Cost of revenue | 2.61bn | 1.73bn |
| Research and development | 1.21bn | 1.18bn |
| Selling, general and administrative | 1.03bn | 901m |
| Operating expenses | 4.86bn | 3.83bn |
| Operating income | −3.50bn | −3.02bn |
| Pre-tax income | −2.70bn | −2.71bn |
| Income tax | −2m | 1m |
| Net income | −2.70bn | −2.71bn |
| Earnings per share | −11.81 | −12.52 |
| Earnings per share, diluted | −12.09 | −12.52 |
| Weighted average shares | 312m | 245m |
| Weighted average shares, diluted | 313m | 245m |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 700m | 998m | 1.64bn | 1.80bn | 1.85bn | 1.61bn | 1.89bn | 1.35bn |
| Short-term investments | 0 | 631m | 702m | 1.03bn | 1.76bn | 2.42bn | 1.58bn | 1.86bn |
| Receivables | 131m | 177m | 138m | 125m | 90m | 112m | 98m | 101m |
| Inventory | 1.47bn | 1.11bn | 981m | 713m | 471m | 408m | 507m | 510m |
| Current assets | 2.76bn | 3.30bn | 3.80bn | 3.95bn | 4.42bn | 4.87bn | 4.25bn | 4.00bn |
| Total assets | 7.48bn | 8.39bn | 8.82bn | 8.87bn | 9.22bn | 9.65bn | 8.49bn | 8.22bn |
| Current liabilities | 2.69bn | 2.64bn | 2.10bn | 1.53bn | 1.33bn | 1.17bn | 1.15bn | 1.01bn |
| Short-term debt | 707m | 672m | — | — | — | 126m | — | — |
| Long-term debt | 2.05bn | 2.05bn | 2.04bn | 2.04bn | 2.00bn | 2.00bn | 2.00bn | 2.00bn |
| Total liabilities | 5.45bn | 5.39bn | 5.10bn | 4.60bn | 4.37bn | 4.48bn | 4.75bn | 4.06bn |
| Equity | −351m | 717m | 1.80bn | 2.41bn | 3.18bn | 3.87bn | 2.68bn | 3.52bn |
| Shares outstanding | 330m | 327m | 324m | 3.07bn | 3.05bn | 303m | 2.34bn | 2.32bn |
| Shares issued | 330m | 327m | 324m | 3.07bn | 3.05bn | 303m | 2.34bn | 2.32bn |
| Treasury shares | 85,782 | 85,782 | 85,782 | 857,825 | 857,825 | 85,782 | 857,825 | 857,825 |
| Metric | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Operating cash flow | −2.93bn | −2.02bn |
| Share-based compensation | 271m | 286m |
| Capital expenditure | 868m | 884m |
| Investing cash flow | 1.48bn | −1.29bn |
| Financing cash flow | 887m | 3.55bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)